Journal article
World Antimalarial Resistance Network (WARN) III: Molecular markers for drug resistant malaria
- Abstract:
-
Molecular markers for drug resistant malaria represent public health tools of great but mostly unrealized potential value. A key reason for the failure of molecular resistance markers to live up to their potential is that data on the their prevalence is scattered in disparate databases with no linkage to the clinical, in vitro and pharmacokinetic data that are needed to relate the genetic data to relevant phenotypes. The ongoing replacement of older monotherapies for malaria by new, more effe...
Expand abstract
- Publication status:
- Published
Actions
Access Document
- Files:
-
-
(pdf, 536.3KB)
-
- Publisher copy:
- 10.1186/1475-2875-6-121
Why is the content I wish to access not available via ORA?
Bibliographic data (the information relating to research outputs) and full-text items (e.g. articles, theses, reports, etc.) arrive in ORA from several different sources. Unfortunately we are not able to make available the full-text for every research output.
Please contact the ORA team (
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
) if you have queries regarding unavailable content OR if you are aware of a full-text copy we can make available.
Content may be unavailable for the following four reasons
-
Version unsuitable
-
We have not obtained a suitable full-text for a given research output. See this page for more information.
-
Recently completed
-
Sometimes content is held in ORA but is unavailable for a fixed period of time to comply with the policies and wishes of rights holders.
-
Permissions
-
All content made available in ORA should comply with relevant rights, such as copyright. See this page for more information.
-
Clearance
-
Some thesis volumes scanned as part of the digitisation scheme funded by Dr Leonard Polonsky are currently unavailable due to sensitive material or uncleared third-party copyright content. We are attempting to contact authors whose theses are affected.
Alternative access to the full-text
You may be able to access the full-text directly from the publisher's website using the 'Publisher Copy' link in the 'Links & Downloads' box from a research output's ORA record page. This method may require an institutional or individual subscription to the journal/resource.
Authors
Bibliographic Details
- Journal:
- Malaria Journal
- Volume:
- 6
- Issue:
- 1
- Pages:
- 121
- Publication date:
- 2007-01-01
- DOI:
- EISSN:
-
1475-2875
- ISSN:
-
1475-2875
- Source identifiers:
-
343933
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:343933
- UUID:
-
uuid:b36b44a1-0495-4158-9ed5-7ad6f5d76b11
- Local pid:
- pubs:343933
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2007
- Notes:
-
Cited By (since 1996): 42 Export Date: 29 July 2012 Source: Scopus Art. No.: 121 Language of Original Document: English Correspondence Address: Sibley, C.H.; Department of Genome Sciences, Box 355065, University of Washington, Seattle, WA 98195, United States; email: sibley@u.washington.edu Chemicals/CAS: amodiaquine, 69-44-3, 86-42-0; artemether plus benflumetol, 141204-94-6; artemisinin, 63968-64-9; artesunate, 82864-68-4, 88495-63-0; benflumetol, 82186-77-4; chloroquine, 132-73-0, 3545-67-3, 50-63-5, 54-05-7; cotrimoxazole, 8064-90-2; mefloquine, 51773-92-3, 53230-10-7; piperaquine, 4085-31-8 References: Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance (2000) Mol Cell, 6, pp. 861-871. , 10.1016/S1097-2765(05)00077-8. 11090624; Sidhu, A.B., Verdier-Pinard, D., Fidock, D.A., Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations (2002) Science, 298, pp. 210-213. , 10.1126/science.1074045. 12364805; Reed, M.B., Saliba, K.J., Caruana, S.R., Kirk, K., Cowman, A.F., Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum (2000) Nature, 403, pp. 906-909. , 10.1038/35002615. 10706290; Price, R.N., Cassar, C., Brockman, A., Duraisingh, M., Van Vugt, M., White, N.J., The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand (1999) Antimicrob Agents Chemother, 43, pp. 2943-2949. , 10582887; Price, R.N., Uhlemann, A.C., Brockman, A., McGready, R., Ashley, E., Phaipun, L., Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number (2004) Lancet, 364, pp. 438-447. , 10.1016/S0140-6736(04)16767-6. 15288742; Duraisingh, M.T., Jones, P., Sambou, I., Von Seidlein, L., Pinder, M., Warhurst, D.C., The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin (2000) Mol Biochem Parasitol, 108, pp. 13-23. , 10.1016/S0166-6851(00)00201-2. 10802315; Peterson, D.S., Walliker, D., Wellems, T.E., Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria (1988) Proc Natl Acad Sci USA, 85, pp. 9114-9118. , 2904149. 10.1073/pnas.85.23.9114; Brooks, D.R., Wang, P., Read, M., Watkins, W.M., Sims, P.F., Hyde, J.E., Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: Dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine (1994) Eur J Biochem, 224, pp. 397-405. , 10.1111/j.1432-1033.1994.00397.x. 7925353; Djimde, A., Doumbo, O.K., Cortese, J.F., Kayentao, K., Doumbo, S., Diourte, Y., A molecular marker for chloroquine-resistant falciparum malaria (2001) N Engl J Med, 344, pp. 257-263. , 10.1056/NEJM200101253440403. 11172152; Djimde, A., Doumbo, O.K., Steketee, R.W., Plowe, C.V., Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria (2001) Lancet, 358, pp. 890-891. , 10.1016/S0140-6736(01)06040-8. 11567708; Djimde, A.A., Dolo, A., Ouattara, A., Diakite, S., Plowe, C.V., Doumbo, O.K., Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones (2004) J Infect Dis, 190, pp. 853-855. , 10.1086/422758. 15272415; Mugittu, K., Ndejembi, M., Malisa, A., Lemnge, M., Premji, Z., Mwita, A., Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance (2004) Am J Trop Med Hyg, 71, pp. 696-702. , 15642957; Kublin, J.G., Cortese, J.F., Njunju, E.M., Mukadam, R.A.G., Wirima, J.J., Kazembe, P.N., Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi (2003) J Infect Dis, 187, pp. 1870-1875. , 10.1086/375419. 12792863; White, N.J., Nosten, F., Looareesuwan, S., Watkins, W.M., Marsh, K., Snow, R.W., Averting a malaria disaster (1999) Lancet, 353, pp. 1965-1967. , 10.1016/S0140-6736(98)07367-X. 10371589; Bzik, D.J., Li, W., Horii, T., Inselburg, J., Molecular cloning and sequence analysis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene (1987) Proc Natl Acad Sci USA, 84, pp. 8360-8364. , 2825189. 10.1073/pnas.84.23.8360; Foote, S.J., Thompson, J.K., Cowman, A.F., Kemp, D.J., Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum (1989) Cell, 57, pp. 921-930. , 10.1016/0092-8674(89)90330-9. 2701941; Wellems, T.E., Walker-Jonah, A., Panton, L.J., Genetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7 (1991) Proc Natl Acad Sci USA, 88, pp. 3382-3386. , 1673031. 10.1073/pnas.88.8.3382; Foote, S.J., Kyle, D.E., Martin, R.K., Oduola, A.M., Forsyth, K., Kemp, D.J., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum (1990) Nature, 345, pp. 255-258. , 10.1038/345255a0. 2185424; Cowman, A.F., Galatis, D., Thompson, J.K., Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdr1 gene and cross-resistance to halofantrine and quinine (1994) Proc Natl Acad Sci USA, 91, pp. 1143-1147. , 8302844. 10.1073/pnas.91.3.1143; Price, R.N., Uhlemann, A.C., Van, V.M., Brockman, A., Hutagalung, R., Nair, S., Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria (2006) Clin Infect Dis, 42, pp. 1570-1577. , 10.1086/503423. 16652314; Wu, Y., Kirkman, L., Wellems, T.E., Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine (1996) Proc Natl Acad Sci USA, 93, pp. 1130-1134. , 8577727. 10.1073/pnas.93.3.1130; Wooden, J.M., Hartwell, L.H., Vasquez, B., Sibley, C.H., Analysis in yeast of antimalaria drugs that target the dihydrofolate reductase of Plasmodium falciparum (1997) Mol Biochem Parasitol, 85, pp. 25-40. , 10.1016/S0166-6851(96)02808-3. 9108546; Cortese, J.F., Plowe, C.V., Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutants expressed in yeast (1998) Mol Biochem Parasitol, 94, pp. 205-214. , 10.1016/S0166-6851(98)00075-9. 9747971; Plowe, C.V., Cortese, J.F., Djimde, A., Nwanyanwu, O.C., Watkins, W.M., Winstanley, P.A., Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance (1997) J Infect Dis, 176, pp. 1590-1596. , 9395372; Wang, P., Lee, C.S., Bayoumi, R., Djimde, A., Doumbo, O., Swedberg, G., Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins (1997) Mol Biochem Parasitol, 89, pp. 161-177. , 10.1016/S0166-6851(97)00114-X. 9364963; Kublin, J.G., Dzinjalamala, F.K., Kamwendo, D.D., Malkin, E.M., Cortese, J.F., Martino, L.M., Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria (2002) J Infect Dis, 185, pp. 380-388. , 10.1086/338566. 11807721; Djimde, A.A., Doumbo, O.K., Traore, O., Guindo, A.B., Kayentao, K., Diourte, Y., Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria (2003) Am J Trop Med Hyg, 69, pp. 558-563. , 14695097; White, N.J., Why is it that antimalarial drug treatments do not always work? (1998) Annals of Tropical Medicine and Parasitology, 92, pp. 449-458. , 10.1080/00034989859429; Dzinjalamala, F.K., MacHeso, A., Kublin, J.G., Taylor, T.E., Barnes, K.I., Molyneux, M.E., Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria (2005) Am J Trop Med Hyg, 72, pp. 267-272. , 15772319; Francis, D., Nsobya, S.L., Talisuna, A., Yeka, A., Kamya, M.R., MacHekano, R., Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance (2006) J Infect Dis, 193, pp. 978-986. , 10.1086/500951. 16518760; Tinto, H., Sanou, B., Dujardin, J.C., Ouedraogo, J.B., Van, O.C., Erhart, A., Usefulness of the Plasmodium falciparum chloroquine resistance transporter T76 genotype failure index for the estimation of in vivo chloroquine resistance in Burkina Faso (2005) Am J Trop Med Hyg, 73, pp. 171-173. , 16014853; Kyabayinze, D., Cattamanchi, A., Kamya, M.R., Rosenthal, P.J., Dorsey, G., Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria (2003) Am J Trop Med Hyg, 69, pp. 247-252. , 14628939; Jambou, R., Legrand, E., Niang, M., Khim, N., Lim, P., Volney, B., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6 (2005) Lancet, 366, pp. 1960-1963. , 10.1016/S0140-6736(05)67787-2. 16325698; Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., Multiple transporters associated with malaria parasite responses to chloroquine and quinine (2003) Mol Microbiol, 49, pp. 977-989. , 10.1046/j.1365-2958.2003.03627.x. 12890022; Volkman, S.K., Sabeti, P.C., Decaprio, D., Neafsey, D.E., Schaffner, S.F., Milner Jr., D.A., A genome-wide map of diversity in Plasmodium falciparum (2007) Nat Genet, 39, pp. 113-119. , 10.1038/ng1930. 17159979; Jeffares, D.C., Pain, A., Berry, A., Cox, A.V., Stalker, J., Ingle, C.E., Genome variation and evolution of the malaria parasite Plasmodium falciparum (2007) Nat Genet, 39, pp. 120-125. , 10.1038/ng1931. 17159978; Plowe, C.V., Djimde, A., Bouare, M., Doumbo, O., Wellems, T.E., Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa (1995) Am J Trop Med Hyg, 52, pp. 565-568. , 7611566; Rojanawatsirivej, C., Vijaykadga, S., Amklad, I., Wilairatna, P., Looareesuwan, S., Monitoring the therapeutic efficacy of antimalarials against uncomplicated falciparum malaria in Thailand (2003) Southeast Asian J Trop Med Public Health, 34, pp. 536-541. , 15115123; Denis, M.B., Tsuyuoka, R., Lim, P., Lindegardh, N., Yi, P., Top, S.N., Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia (2006) Trop Med Int Health, 11, pp. 1800-1807. , 10.1111/j.1365-3156.2006.01739.x. 17176344; Alker, A.P., Lim, P., Sem, R., Shah, N.K., Yi, P., Bouth, D.M., Pfmdr1 and in vivo resistance to artesunate-mefloquine in Falciparum malaria on the Cambodian-Thai border (2007) Am J Trop Med Hyg, 76, pp. 641-647. , 17426163; Bloland, P.B., Lackritz, E.M., Kazembe, P.N., Were, J.B., Steketee, R., Campbell, C.C., Beyond chloroquine: Implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa (1993) J Infect Dis, 167, pp. 932-937. , 8450258; Laufer, M.K., Thesing, P.C., Eddington, N.D., Masonga, R., Dzinjalamala, F.K., Takala, S.L., Return of chloroquine antimalarial efficacy in Malawi (2006) N Engl J Med, 355, pp. 1959-1966. , 10.1056/NEJMoa062032. 17093247; Dorsey, G., Njama, D., Kamya, M.R., Cattamanchi, A., Kyabayinze, D., Staedke, S.G., Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: A longitudinal randomised trial (2002) Lancet, 360, pp. 2031-2038. , 10.1016/S0140-6736(02)12021-6. 12504399; Zongo, I., Dorsey, G., Rouamba, N., Tinto, H., Dokomajilar, C., Guiguemde, R.T., Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: A randomised non-inferiority trial (2007) Lancet, 369, pp. 491-498. , 10.1016/S0140-6736(07)60236-0. 17292769; Rogerson, S.J., Chaluluka, E., Kanjala, M., Mkundika, P., Mhango, C., Molyneux, M.E., Intermittent sulfadoxine-pyrimethamine in pregnancy: Effectiveness against malaria morbidity in Blantyre, Malawi, in 1997-99 (2000) Trans R Soc Trop Med Hyg, 94, pp. 549-553. , 10.1016/S0035-9203(00)90083-X. 11132387; Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: A randomised, placebo-controlled trial (2001) Lancet, 357, pp. 1471-1477. , 10.1016/S0140-6736(00)04643-2. 11377597; Hamel, M.J., Holtz, T., Mkandala, C., Kaimila, N., Chizani, N., Bloland, P., Efficacy of trimethoprim-sulfamethoxazole compared with sulfadoxine-pyrimethamine plus erythromycin for the treatment of uncomplicated malaria in children with integrated management of childhood illness dual classifications of malaria and pneumonia (2005) Am J Trop Med Hyg, 73, pp. 609-615. , 16172491; Mermin, J., Bunnell, R., Lule, J., Opio, A., Gibbons, A., Dybul, M., Developing an evidence-based, preventive care package for persons with HIV in Africa (2005) Trop Med Int Health, 10, pp. 961-970. , 10.1111/j.1365-3156.2005.01488.x. 16185230; Thera, M.A., Sehdev, P.S., Coulibaly, D., Traore, K., Garba, M.N., Cissoko, Y., Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease (2005) J Infect Dis, 192, pp. 1823-1829. , 10.1086/498249. 16235184; Iyer, J.K., Milhous, W.K., Cortese, J.F., Kublin, J.G., Plowe, C.V., Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine (2001) Lancet, 358, pp. 1066-1067. , 10.1016/S0140-6736(01)06201-8. 11589941; Triglia, T., Wang, P., Sims, P.F., Hyde, J.E., Cowman, A.F., Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria (1998) EMBO J, 17, pp. 3807-3815. , 9669998. 10.1093/emboj/17.14.3807; Malamba, S.S., Mermin, J., Reingold, A., Lule, J.R., Downing, R., Ransom, R., Effect of cotrimoxazole prophylaxis taken by human immunodeficiency virus (HIV)-infected persons on the selection of sulfadoxine-pyrimethamine-resistant malaria parasites among HIV-uninfected household members (2006) Am J Trop Med Hyg, 75, pp. 375-380. , 16968909; Laufer, M.K., Plowe, C.V., Cotrimoxazole prophylaxis and malaria in Africa: Have the important questions been answered? (2006) Am J Trop Med Hyg, 75, pp. 373-374. , 16968908; Laufer, M.K., Plowe, C.V., Withdrawing antimalarial drugs: Impact on parasite resistance and implications for malaria treatment policies (2004) Drug Resist Updat, 7, pp. 279-288. , 10.1016/j.drup.2004.08.003. 15533765; Dokomajilar, C., Lankoande, Z.M., Dorsey, G., Zongo, I., Ouedraogo, J.B., Rosenthal, P.J., Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso (2006) Am J Trop Med Hyg, 75, pp. 162-165. , 16837725; Humphreys, G.S., Merinopoulos, I., Ahmed, J., Whitty, C.J., Mutabingwa, T.K., Sutherland, C.J., Amodiaquine and artemether-lumefantrine select distinct alleles of the P. falciparum pfmdr1 gene in Tanzanian children treated for uncomplicated malaria (2006) Antimicrob Agents Chemother, , 17194834; Sisowath, C., Stromberg, J., Martensson, A., Msellem, M., Obondo, C., Bjorkman, A., In vivo selection of Plasmodium falciparum pfmdr1 86N coding alleles by artemether-lumefantrine (Coartem) (2005) J Infect Dis, 191, pp. 1014-1017. , 10.1086/427997. 15717281; Dokomajilar, C., Nsobya, S.L., Greenhouse, B., Rosenthal, P.J., Dorsey, G., Selection of Plasmodium falciparum pfmdr1 alleles following therapy with artemether-lumefantrine in an area of Uganda where malaria is highly endemic (2006) Antimicrob Agents Chemother, 50, pp. 1893-1895. , 16641472. 10.1128/AAC.50.5.1893-1895.2006; Ferdig, M.T., Cooper, R.A., Mu, J., Deng, B., Joy, D.A., Su, X.Z., Dissecting the loci of low-level quinine resistance in malaria parasites (2004) Mol Microbiol, 52, pp. 985-997. , 10.1111/j.1365-2958.2004.04035.x. 15130119; Mu, J., Awadalla, P., Duan, J., McGee, K.M., Keebler, J., Seydel, K., Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome (2007) Nat Genet, 39, pp. 126-130. , 10.1038/ng1924. 17159981; Jelinek, T., Peyerl-Hoffmann, G., Muhlberger, N., Wichmann, O., Wilhelm, M., Schmider, N., Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe (2002) Malar J, 1, p. 11. , 12423552. 10.1186/1475-2875-1-11; Labbe, A.C., Patel, S., Crandall, I., Kain, K.C., A molecular surveillance system for global patterns of drug resistance in imported malaria (2003) Emerg Infect Dis, 9, pp. 33-36. , 12533279; Schwartz, E., Bujanover, S., Kain, K.C., Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa (2003) Clin Infect Dis, 37, pp. 450-451. , 10.1086/375599. 12884171; Wu, Y., Fairfield, A.S., Oduola, A., Cypess, R.H., The Malaria Research and Reference Reagent Resource (MR4) Center - creating African opportunities (2001) Afr J Med Med Sci, 30 (SUPPL.), pp. 52-54. , 14513940; Baird, J.K., Basri, H., Purnomo, Bangs, M.J., Subianto, B., Patchen, L.C., Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia (1991) Am J Trop Med Hyg, 44, pp. 547-552. , 1676566; Eldin De Pecoulas, P., Tahar, R., Ouatas, T., Mazabraud, A., Basco, L.K., Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance (1998) Mol Biochem Parasitol, 92, pp. 265-273. , 10.1016/S0166-6851(97)00247-8. 9657331; Auliff, A., Wilson, D.W., Russell, B., Gao, Q., Chen, N., Ln, A., Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs (2006) Am J Trop Med Hyg, 75, pp. 617-621. , 17038682; Mapping Malaria Risk in Africa, , http://www.mara.org.za
Molecular markers for drug resistant malaria represent public health tools of great but mostly unrealized potential value. A key reason for the failure of molecular resistance markers to live up to their potential is that data on the their prevalence is scattered in disparate databases with no linkage to the clinical, in vitro and pharmacokinetic data that are needed to relate the genetic data to relevant phenotypes. The ongoing replacement of older monotherapies for malaria by new, more effective combination therapies presents an opportunity to create an open access database that brings together standardized data on molecular markers of drug resistant malaria from around the world. This paper presents a rationale for creating a global database of molecular markers for drug resistant malaria and for linking it to similar databases containing results from clinical trials of drug efficacy, in vitro studies of drug susceptibility, and pharmacokinetic studies of antimalarial drugs, in a World Antimalarial Resistance Network (WARN). This database will be a global resource, guiding the selection of first line drugs for treating uncomplicated malaria, for preventing malaria in travelers and for intermittent preventive treatment of malaria in pregnant women, infants and other vulnerable groups. Perhaps most important, a global database for molecular markers of drug resistant malaria will accelerate the identification and validation of markers for resistance to artemisinin-based combination therapies and, thereby, potentially prolong the useful therapeutic lives of these important new drugs. © 2007 Plowe et al; licensee BioMed Central Ltd.
If you are the owner of this record, you can report an update to it here: Report update to this record